Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
source: pixabay.com

Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment

Albireo has recently initiated their Phase 3 ASSERT trial, according to GlobeNewswire. This study will evaluate odevixibat as a treatment for Alagille syndrome. This therapy fits well with Albireo's mission,…

Continue Reading Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
Use of Tissue Type Plasminogen Activator in Sickle Cell Disease Patients Experiencing Stroke
source: pixabay.com

Use of Tissue Type Plasminogen Activator in Sickle Cell Disease Patients Experiencing Stroke

by Lauren Taylor from In The Cloud Copy Sickle cell disease or SCD is a type of red blood cell disorder in which the normally round red blood cells are…

Continue Reading Use of Tissue Type Plasminogen Activator in Sickle Cell Disease Patients Experiencing Stroke
Uncommon Forms of Diabetes to be Studied in First-Ever NIH Funded Nationwide, Multicenter Study
source: pixabay.com

Uncommon Forms of Diabetes to be Studied in First-Ever NIH Funded Nationwide, Multicenter Study

by Danielle Bradshaw from In The Cloud Copy The National Institutes of Health is funding a study throughout the entire United States with the goal of figuring out what causes…

Continue Reading Uncommon Forms of Diabetes to be Studied in First-Ever NIH Funded Nationwide, Multicenter Study
Study Provides Evidence That Lupus Nephritis Seemingly Doesn’t Increase Chances of Severe Infection
source: pixabay.com

Study Provides Evidence That Lupus Nephritis Seemingly Doesn’t Increase Chances of Severe Infection

by Danielle Bradshaw from In The Cloud Copy Research that has recently been made available reveals that lupus nephritis - a kind of kidney disease that’s related to lupus -…

Continue Reading Study Provides Evidence That Lupus Nephritis Seemingly Doesn’t Increase Chances of Severe Infection
Sitting Position Linked to Reduced Cerebral Blood Flow in Patients with Myalgic Encephalomyelitis
source: pixabay.com

Sitting Position Linked to Reduced Cerebral Blood Flow in Patients with Myalgic Encephalomyelitis

by Lauren Taylor from In The Cloud Copy Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition in which the affected patient has overwhelming fatigue that does not improve even…

Continue Reading Sitting Position Linked to Reduced Cerebral Blood Flow in Patients with Myalgic Encephalomyelitis
Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Dysautonomia May Have Treatable Underlying Autoimmune Disease
source: pixabay.com

Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Dysautonomia May Have Treatable Underlying Autoimmune Disease

by Lauren Taylor from In The Cloud Copy Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complicated and debilitating condition in which affected individuals are unable to perform their daily activities…

Continue Reading Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Dysautonomia May Have Treatable Underlying Autoimmune Disease
Gulf War Illness and Chronic Fatigue Syndrome Show Distinct Brain Differences, Contrary to Previous Theories
source: pixabay.com

Gulf War Illness and Chronic Fatigue Syndrome Show Distinct Brain Differences, Contrary to Previous Theories

by Lauren Taylor from In The Cloud Copy Gulf war illness (GWI) is a chronic condition that is considered multi-symptomatic, meaning there are a wide range of chronic and acute…

Continue Reading Gulf War Illness and Chronic Fatigue Syndrome Show Distinct Brain Differences, Contrary to Previous Theories
Experimental Treatment Reduces Retinal Thinning in Progressive Multiple Sclerosis
source: pixabay.com

Experimental Treatment Reduces Retinal Thinning in Progressive Multiple Sclerosis

According to a story from GlobeNewswire, the biopharmaceutical company MediciNova, Inc. has announced encouraging results related in Optical Coherence Tomography (OCT) in a phase 2b clinical trial. This clinical trial…

Continue Reading Experimental Treatment Reduces Retinal Thinning in Progressive Multiple Sclerosis